EMA starts safety referral for prostate cancer drug

The European Medicines Agency ’s Pharmacovigilance Risk Assessment Committee has begun two new safety-related referrals
Source: The Pharmaceutical Journal - Category: Drugs & Pharmacology Source Type: research